Video Experimental Relacionado
Updated: Jan 8, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Ivonescimab para carcinoma adenoescamoso de pulmón con mutación EGFR tras multiterapia: Un reporte de caso
Xiaohua Pan1, Jianya Zhang2, Chao Ye2
1School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Un paciente con cáncer de pulmón avanzado con mutación EGFR resistente a múltiples tratamientos respondió rápidamente a ivonescimab, un nuevo anticuerpo bispecífico PD-1/VEGF-A. Esto resalta su potencial para superar la resistencia en el cáncer de pulmón no microcítico (CPNM) de difícil tratamiento.
Más Videos Relacionados
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
Videos de Conceptos Relacionados
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy